Bailey Fisher Executive Search is pleased to have worked with Sense Biodetection on the search for a Chairman, resulting in the appointment of Heiner Dreismann.
Sense Biodetection Limited (Sense) is an early stage, venture backed molecular diagnostics business, based in Oxford and Cambridge. Following an international search, Bailey Fisher sourced Heiner Dreismann, a leading light in molecular diagnostics, with 35 years’ experience leading high-growth businesses on a global basis. Heiner was previously President and CEO of Roche Molecular Systems, the world leader in molecular diagnostics.
During his tenure at Roche Molecular Systems, Heiner oversaw the substantial growth of the PCR business, with revenues doubling in five years. In his earlier career at Roche, Heiner led the integration office of the successful acquisition of Boehringer Mannheim into Roche Diagnostics, and went on to become Head of Global Business Development with responsibility for the entire diagnostics business.
Commenting on his appointment, Heiner said: “I am delighted to join Sense at this exciting stage in its development and to be in a position to help the company achieve its ambitious plans. Sense has a compelling proposition and a significant opportunity to transform the IVD field with a new class of molecular diagnostic product.”❰ Back